1st International Symposium

The Symposium

1st International Symposium:   “The Symposium: “Mechanisms of Cancer and New Therapeutic Strategies”

The goal of our first symposium is to officially introduce our program and our research, and to bring together bright minds at the forefronts of cancer research and its application in the clinic.

In addition, in the context of the meeting we will also have a patients’ session where we will inform general public and oncology patients of our translational and clinical assets at the Bellvitge campus.

Álvaro Aytés

Resistance and Progression Mechanisms in Prostate Cancer Group, Oncobell Program, IDIBELL, Barcelona

Isabel Fabregat

TGF-beta and Cancer Group, Oncobell Program, IDIBELL, Barcelona

Cristina Muñoz-Pinedo

Cell Death Regulation Group, Oncobell Program, IDIBELL, Barcelona

Ramon Salazar

Oncobell Program Coordinator, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona

George Thomas

Metabolism and Cancer Group, Oncobell Program, IDIBELL, Barcelona.

With the collaboration of Astellas Pharma